Home / Inspections / 1028732

FDA Inspection 1028732 — Baxter Pharmaceuticals India Pvt Ltd

Baxter Pharmaceuticals India Pvt Ltd — FEI 3004610460

The FDA completed an inspection of Baxter Pharmaceuticals India Pvt Ltd on August 4, 2017 in Ahmedabad. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 4, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)

Facility

Other inspections at this facility

  • 1195842 (OAI Fri Jan 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1169631 (VAI Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986348 (VAI Fri Aug 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929802 (VAI Mon May 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853758 (VAI Fri Oct 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources